| Literature DB >> 28509846 |
Jidapa Noinart1, Suradet Buttachon2,3, Tida Dethoup4, Luís Gales5,6, José A Pereira7,8, Ralph Urbatzka9, Sara Freitas10, Michael Lee11, Artur M S Silva12, Madalena M M Pinto13,14, Vítor Vasconcelos15,16, Anake Kijjoa17,18.
Abstract
A new ergosterol analog, talarosterone (1) and a new bis-anthraquinone derivative (3) were isolated, together with ten known compounds including palmitic acid, ergosta-4,6,8(14),22-tetraen-3-one, ergosterol-5,8-endoperoxide, cyathisterone (2), emodin (4a), questinol (4b), citreorosein (4c), fallacinol (4d), rheoemodin (4e) and secalonic acid A (5), from the ethyl acetate extract of the culture of the marine sponge-associated fungus Talaromyces stipitatus KUFA 0207. The structures of the new compounds were established based on extensive 1D and 2D spectral analysis, and in the case of talarosterone (1), the absolute configurations of its stereogenic carbons were determined by X-ray crystallographic analysis. The structure and stereochemistry of cyathisterone (2) was also confirmed by X-ray analysis. The anthraquinones 4a-e and secalonic acid A (5) were tested for their anti-obesity activity using the zebrafish Nile red assay. Only citreorosein (4c) and questinol (4b) exhibited significant anti-obesity activity, while emodin (4a) and secalonic acid A (5) caused toxicity (death) for all exposed zebrafish larvae after 24 h.Entities:
Keywords: Talaromyces stipitatus; Trichocomaceae; anthraquinones; anti-obesity; bis-anthraquinone; ergosterol derivatives; secalonic acid A; zebrafish Nile red assay
Mesh:
Substances:
Year: 2017 PMID: 28509846 PMCID: PMC5450545 DOI: 10.3390/md15050139
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Secondary metabolites from Talaromyces stipitatus KUFA 0207.
1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 1.
| Position | δC, Type | δH, ( | COSY | ROESY | HMBC |
|---|---|---|---|---|---|
| 1α | 37.1, CH2 | 1.81, m | |||
| β | 2.18, m | ||||
| 2α | 33.8, CH2 | 2.50,m | H-1 | ||
| β | 2.64, dd (17.9, 7.2) | H-1 | |||
| 3 | 199.5, CO | - | |||
| 4 | 129.2, CH | 6.66, d (0.8) | - | C-2, 3, 5 | |
| 5 | 155.0, C | - | |||
| 6 | 195.9, CO | - | |||
| 7 | 56.1, CH | 3.20, s | - | H-9, 14, 15 | C-5, 6, 8, 14 |
| 8 | 66.2, C | - | |||
| 9 | 43.9, CH | 1.90, m | |||
| 10 | 36.8, C | - | |||
| 11 | 20.7, CH2 | 1.85, m | |||
| 12 | 39.0, CH2 | 1.21, m; 1.40, m | |||
| 13 | 44.3, C | - | |||
| 14 | 51.8, CH | 1.94, m | |||
| 15 | 18.7, CH2 | 1.25, m | |||
| 16 | 27.7, CH2 | 1.34, m; 1.75, m | |||
| 17 | 56.0, CH | 1.30, m | |||
| 18 | 12.4, CH3 | 0.89, s | C-12, 13, 14, 17 | ||
| 19 | 21.8, CH3 | 1.50, s | - | 1β, 2β | C-1, 5, 9 |
| 20 | 40.0, CH | 2.04, m | |||
| 21 | 21.0 CH3 | 1.04, d (6.8) | H-20 | C-17, 20, 22 | |
| 22 | 135.0, CH | 5.15, dd (15.3, 7.3) | H-20, 23 | C-21, 24 | |
| 23 | 132.5, CH | 5.25, dd (15.3, 8.0) | H-22, 24 | C-20, 24, 25, 26 | |
| 24 | 42.8, CH | 1.85, m | C-22, 23 | ||
| 25 | 33.0, CH | 1.48, m | |||
| 26 | 17.6, CH3 | 0.92, d (6.8) | H-24 | C-23, 24, 25 | |
| 27 | 20.0, CH3 | 0.82, d (6.8) | H-25 | C-24, 25, 28 | |
| 28 | 19.6 CH3 | 0.84, d (6.8) | H-25 | C-24, 25, 27 |
Figure 2Key COSY () and HMBC () correlations of compound 1.
Figure 3Key ROESY correlations () of compound 1.
Figure 4ORTEP diagram of compound 1.
Figure 5ORTEP diagram of compound 2.
1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment for 3.
| Position | δC, Type | δH, ( | COSY | HMBC |
|---|---|---|---|---|
| 1 (1′) | 164.3, C | - | ||
| 2 (2′) | 123.5, C | - | ||
| 3 (3′) | 107.2, CH | 6.73, s | - | C-1 (1′), 4 (4′), 2 (2′), 4a (4′a) |
| 4 (4′) | 108.9, C | - | ||
| 4a (4′a) | 108.9, C | - | ||
| 5 (5′) | 161.1, C | - | ||
| 6 (6′) | 123.6, CH | 7.15, dd (1.0, 0.5) | H-8 (8′), Me-7 (7′) | C-5 (5′), 7 (7′), 8 (8′), 10a (10′a) |
| 7 (7′) | 148.2, C | - | ||
| 8 (8′) | 120.5, CH | 7.28, dd (1.0, 0.5) | H-6 (6′), Me-7 (7′) | C-6 (6′), 7 (7′), 9 (9′), 10a (10′a) |
| 8a (8′a) | 131.3, C * | - | ||
| 9 (9′) | 182.1, CO | - | ||
| 9a (9′a) | 133.2, C * | - | ||
| 10 (10′) | 189.6, CO | - | ||
| 10a (10′a) | 113.1, C | - | ||
| CH3-7 (7′) | 21.5, CH3 | 2.33, s | H-6 (6′), 8 (8′) | C-6 (6′), 7 (7′), 8 (8′) |
| OH-4 (4′) | - | 12.79, s | - | C-3 (3′), 4 (4′), 4a (4′a) |
| OH-5 (5′) | - | 12.04, s | - | C-5 (5′), 6 (6′), 10a (10′a) |
* can be interchanged.
Figure 6Key COSY () and HMBC () correlations of compound 3.
Figure 7Anti-obesity activity of compounds 4a–e and 5 in the zebrafish larvae Nile red assay. The solvent control had 0.1% DMSO and the positive control received 50 µM resveratrol (REV). Values are presented as mean fluorescence intensity (MFI) relative to the DMSO group, and are derived from 10 to 12 individual larvae per treatment group. Statistical differences to the solvent control are indicated with asterisks, *** = p < 0.001.
Figure 8Representative images of the zebrafish Nile red assay. The upper images show the overlay of the fluorescence and phase contrast; the lower images show the mean fluorescence intensity (MFI) given as black and white picture. DMSO, solvent control 0.1%.